Satellos Bioscience Inc. (MSCLF)
MSCLF Stock Price Chart
Explore Satellos Bioscience Inc. interactive price chart. Choose custom timeframes to analyze MSCLF price movements and trends.
MSCLF Company Profile
Discover essential business fundamentals and corporate details for Satellos Bioscience Inc. (MSCLF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Aug 2012
Employees
14.00
Website
https://satellos.comCEO
Francis Gleeson
Description
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.
MSCLF Financial Timeline
Browse a chronological timeline of Satellos Bioscience Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.02 surpassing the estimated -$0.02 by +10.59%.
Earnings released on 13 May 2025
EPS came in at -$0.04 falling short of the estimated -$0.03 by -27.19%.
Earnings released on 26 Mar 2025
EPS came in at -$0.01 surpassing the estimated -$0.05 by +80.00%.
Earnings released on 13 Nov 2024
EPS came in at -$0.06 falling short of the estimated -$0.05 by -20.00%.
Earnings released on 12 Aug 2024
EPS came in at -$0.04 surpassing the estimated -$0.05 by +20.00%.
Earnings released on 14 May 2024
EPS came in at -$0.04 falling short of the estimated -$0.04 by -8.37%.
Earnings released on 27 Mar 2024
EPS came in at -$0.04 falling short of the estimated -$0.01 by -300.00%.
Earnings released on 22 Nov 2023
EPS came in at -$0.02 matching the estimated -$0.02.
Earnings released on 28 Aug 2023
EPS came in at -$0.04 falling short of the estimated -$0.03 by -33.33%.
Earnings released on 30 May 2023
EPS came in at -$0.03 surpassing the estimated -$0.04 by +25.00%.
Earnings released on 30 Mar 2023
EPS came in at -$0.10 falling short of the estimated -$0.09 by -7.41%.
Earnings released on 23 Nov 2022
EPS came in at -$0.04 surpassing the estimated -$0.05 by +20.00%.
Earnings released on 29 Aug 2022
EPS came in at -$0.05 .
Earnings released on 30 May 2022
EPS came in at -$0.05 .
Earnings released on 29 Apr 2022
EPS came in at -$0.05 .
Earnings released on 29 Nov 2021
EPS came in at -$0.34 .
Earnings released on 31 Aug 2021
EPS came in at -$0.01 .
Stock split effective on 18 Aug 2021
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Apr 2021
Earnings released on 31 Mar 2021
EPS came in at -$0.02 .
Earnings released on 24 Nov 2020
EPS came in at -$0.01 .
Earnings released on 30 Sept 2020
EPS came in at -$0.02 .
MSCLF Stock Performance
Access detailed MSCLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.